Yeruusaalem, 25 Sebteembar, 2025 (TPS-IL) — Shirkadda tignoolajiyada caafimaadka ee Israa’iil Techsomed ayaa heshay ogolaansho ka timid Hay’adda Cuntada iyo Dawooyinka ee Maraykanka (FDA) si ay u ballaariso barxadeeda BioTraceIO360 si ay u marto howlaha kelyaha, marka lagu daro codsiyadeeda beerka. Software-kan oo ay taageerayso AI wuxuu ka caawiyaa dhakhaatiirta inay qorsheeyaan, haggaan, oo ay xaqiijiyaan daawaynta aan qalliinka ahayn, isagoo siinaya beddelka qalliinka ee bukaanada qaba kansarka kelyaha.
“U ballaarinta BioTraceIO360 beerka ilaa kelyaha waxay abuureysaa barxad mideysan oo siisa dhakhaatiirta saxnaan iyo kalsooni dheeraad ah,” ayuu yiri Yossi Abu, Madaxa Fulinta ee Techsomed. Talaabadan waxay horumarinaysaa yoolka Techsomed ee ah in la mideeyo daawaynta lagu hago sawirada ee xubnaha kala duwan.



